286 related articles for article (PubMed ID: 22339988)
21. Plasma sex steroid hormones and breast cancer risk in Chinese women.
Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
[TBL] [Abstract][Full Text] [Related]
22. Neighborhood walkability and sex steroid hormone levels in women.
India-Aldana S; Rundle AG; Clendenen TV; Quinn JW; Arslan AA; Afanasyeva Y; Koenig KL; Liu M; Neckerman KM; Thorpe LE; Zeleniuch-Jacquotte A; Chen Y
Environ Res; 2022 Dec; 215(Pt 2):114285. PubMed ID: 36088991
[TBL] [Abstract][Full Text] [Related]
23. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort.
Schernhammer ES; Sperati F; Razavi P; Agnoli C; Sieri S; Berrino F; Krogh V; Abbagnato C; Grioni S; Blandino G; Schunemann HJ; Muti P
Breast Cancer Res; 2013 Jun; 15(3):R46. PubMed ID: 23777922
[TBL] [Abstract][Full Text] [Related]
24. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
Rinaldi S; Dossus L; Lukanova A; Peeters PH; Allen NE; Key T; Bingham S; Khaw KT; Trichopoulos D; Trichopoulou A; Oikonomou E; Pera G; Larrañaga N; Martinez-Garcia C; Ardanaz E; Quirós JR; Tormo MJ; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Linseisen J; Schulz M; Boeing H; van Gils CH; Bueno-de-Mesquita BH; Pala V; Palli D; Panico S; Tumino R; Vineis P; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC; Lundin E; Agren A; Berglund G; Manjer J; Kumle M; Lund E; Slimani N; Saracci R; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):23-9. PubMed ID: 17220328
[TBL] [Abstract][Full Text] [Related]
25. Androgens and breast cancer in premenopausal women.
Secreto G; Toniolo P; Pisani P; Recchione C; Cavalleri A; Fariselli G; Totis A; Di Pietro S; Berrino F
Cancer Res; 1989 Jan; 49(2):471-6. PubMed ID: 2521298
[TBL] [Abstract][Full Text] [Related]
26. The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States).
Dorgan JF; Reichman ME; Judd JT; Brown C; Longcope C; Schatzkin A; Campbell WS; Franz C; Kahle L; Taylor PR
Cancer Causes Control; 1994 Jan; 5(1):53-60. PubMed ID: 8123779
[TBL] [Abstract][Full Text] [Related]
27. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women.
Stanczyk FZ; Chaikittisilpa S; Sriprasert I; Rafatnia A; Nadadur M; Mishell DR
Climacteric; 2019 Apr; 22(2):169-174. PubMed ID: 30612472
[TBL] [Abstract][Full Text] [Related]
28. Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study.
Hautanen A; Mänttäri M; Manninen V; Tenkanen L; Huttunen JK; Frick MH; Adlercreutz H
Atherosclerosis; 1994 Feb; 105(2):191-200. PubMed ID: 8003095
[TBL] [Abstract][Full Text] [Related]
29. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.
Burger HG; Dudley EC; Cui J; Dennerstein L; Hopper JL
J Clin Endocrinol Metab; 2000 Aug; 85(8):2832-8. PubMed ID: 10946891
[TBL] [Abstract][Full Text] [Related]
30. Serum sex hormone levels are related to breast cancer risk in postmenopausal women.
Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):583-5. PubMed ID: 9167999
[TBL] [Abstract][Full Text] [Related]
31. Urinary equol is associated with bioavailable testosterone but not total testosterone in women.
Dong H; Xiong F; Zhong Q; Li Y; Liu M; Ling W; Tang X; Chen Y
Endocr J; 2020 Mar; 67(3):257-266. PubMed ID: 31748434
[TBL] [Abstract][Full Text] [Related]
32. Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.
Mori N; Keski-Rahkonen P; Gicquiau A; Rinaldi S; Dimou N; Harlid S; Harbs J; Van Guelpen B; Aune D; Cross AJ; Tsilidis KK; Severi G; Kvaskoff M; Fournier A; Kaaks R; Fortner RT; Schulze MB; Jakszyn P; Sánchez MJ; Colorado-Yohar SM; Ardanaz E; Travis R; Watts EL; Masala G; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Gram IT; Waaseth M; Gunter MJ; Murphy N
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805742
[TBL] [Abstract][Full Text] [Related]
33. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
34. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
35. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort.
Verheus M; Peeters PH; van Noord PA; van der Schouw YT; Grobbee DE; van Gils CH
Breast Cancer Res; 2007; 9(4):R53. PubMed ID: 17692133
[TBL] [Abstract][Full Text] [Related]
36. Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
Faupel-Badger JM; Prindiville SA; Venzon D; Vonderhaar BK; Zujewski JA; Eng-Wong J
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1153-8. PubMed ID: 16775175
[TBL] [Abstract][Full Text] [Related]
37. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D; Smith S; Zacur H
Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
[TBL] [Abstract][Full Text] [Related]
38. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
39. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379
[TBL] [Abstract][Full Text] [Related]
40. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction.
Guay A; Munarriz R; Jacobson J; Talakoub L; Traish A; Quirk F; Goldstein I; Spark R
Int J Impot Res; 2004 Apr; 16(2):112-20. PubMed ID: 14999217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
